Newly-Public New Haven Biotech Assembles Downtown Portfolio
With a May 8 sale, New Haven-based Biohaven Pharmaceuticals now controls three properties on Church Street in the city’s downtown: its current home plus neighboring parcels on either side.
by James Sanna | May 14, 2024 | Commercial & Industrial, CR Daily, Industry News
With a May 8 sale, New Haven-based Biohaven Pharmaceuticals now controls three properties on Church Street in the city’s downtown: its current home plus neighboring parcels on either side.
We're sorry, it appears you don't have the proper subscription to view this page. Please click the button below to purchase or renew your subscription and gain access to this content.
Questions? Please contact us at 617.896.5367, or send us an email at subscriptions@thewarrengroup.com.
It appears someone has logged in to your account from another device. Please click the button below to log back in on this device, and terminate all other sessions.
Questions? Please contact us at 617.896.5367, or send us an email at subscriptions@thewarrengroup.com.
Already have a subscription?
Need a subscription?
Just looking for the headlines?
If you need assistance with your subscription, please visit our customer service form or email customerservice@thewarrengroup.com.